Publications | Aster Insights

Filters

Research Focus

Artificial Intelligence/ Machine Learning
Biomarkers
Cancer Disparities
Cancer Prevention
Clinical Trial
Drug Resistance
Gene Signatures
Immuno-oncology
Molecular Genetics/ Genomics
Radiation Oncology
Tumor Microbiome
Tumor Microenvironment

Cancer Type

Breast
Gastrointestinal
Genitourinary
Gynecologic
Head and Neck
Hematologic
Lung
Pan-cancer
Sarcoma
Skin

Data Utilized

ORIEN Avatar (multi-institution)
ORIEN Avatar (single institution)
Total Cancer Care

ORDER BY

All Publications

A Pilot Proteogenomic Study with Data Integration Identifies MCT1 and GLUT1 as Prognostic Markers in Lung Adenocarcinoma. Stewart PA, Parapatics K, Welsh EA, et al.

2015

Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer. Torres-Roca JF, Fulp WJ, Caudell JJ, et al.

2015

A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation. Prokopiou S, Moros EG, Poleszczuk J, et al.

2015

The PIM inhibitor AZD1208 synergizes with ruxolitinib to induce apoptosis of ruxolitinib sensitive and resistant JAK2-V617F-driven cells and inhibit colony formation of primary MPN cells. Mazzacurati L, Lambert QT, Pradhan A, et al.

2015

Radiosensitivity index predicts for survival with adjuvant radiation in resectable pancreatic cancer. Strom T, Hoffe SE, Fulp W, et al.

2015

Overexpression of major CDKN3 transcripts is associated with poor survival in lung adenocarcinoma. Fan C, Chen L, Huang Q, et al.

2015

Cancer: Reshaping the cancer clinic. Schmidt C

2015

Chemoprevention Trial Feasibility Using Botanicals in Exceptionally High Risk Populations for Lung Cancer. Kumar NB, Quinn GP, Alexandrow MG, et al.

2014

Evaluating melanoma drug response and therapeutic escape with quantitative proteomics. Rebecca VW, Wood E, Fedorenko IV, et al.

2014

Collaborative Biomedicine in the Age of Big Data: The Case of Cancer. Shaikh AR, Butte AJ, Schully SD, et al.

2014

Pages: 12345678910111213

Whitepapers

Consensus Molecular Subtype Analyses in Colorectal Cancer Samples

April 2023
Authors: David M. McKean, PhD, Daniel Elgort, PhD, Oliver A. Hampton, PhD, MS, Phaedra Agius, PhD

Read Whitepaper

Independent confirmation of the prognostic significance of an immune-related signature in clear cell renal cell carcinoma utilizing real world clinicogenomic data

April 2023
Authors: Michael Radmacher, PhD, Daniel Elgort, PhD, Oliver A. Hampton, PhD, MS, and Phaedra Agius, PhD

Read Whitepaper